纽约地区5700例COVID-19住院患者的临床表现、合并症与结局
该病例系列纳入2020年3月1日至4月4日纽约Northwell Health系统12家医院连续住院的5700例SARS-CoV-2核酸检测阳性患者,中位年龄63岁,39.7%为女性。最常见合并症为高血压(56.6%)、肥胖(41.7%)和糖尿病(33.8%);分诊时30.7%发热,17.3%呼吸频率大于24次/分,27.8%接受补氧。在终点时已出院或死亡的2634例中,14.2%入住ICU,12.2%接受有创机械通气,3.2%接受肾脏替代治疗,21%死亡。截至2020年4月4日,需机械通气的1151例(20.2%)中3.3%存活出院、24.5%死亡、72.2%仍在院。
要点
- 在终点时已出院或死亡的2634例中,553例(21%)死亡,320例(12.2%)接受有创机械通气,81例(3.2%)接受肾脏替代治疗。
- 截至2020年4月4日,需有创机械通气的1151例(20.2%)中仅38例(3.3%)存活出院,282例(24.5%)死亡,831例(72.2%)仍在院。
- 分诊时仅30.7%发热、17.3%呼吸频率大于24次/分,27.8%需补氧,呼吸道病毒共感染率仅2.1%。
- 最常见合并症为高血压(3026例,56.6%)、肥胖(1737例,41.7%)和糖尿病(1808例,33.8%)。
- 研究期间45例(2.2%)再入院,再入院中位时间为3天(IQR 1.0-4.5)。
适用人群与场景
- 2020年3月1日至4月4日期间在纽约市、长岛和韦斯特切斯特县Northwell Health系统12家医院连续住院、鼻咽拭子PCR检测SARS-CoV-2阳性的患者。
- 共纳入5700例,中位年龄63岁(IQR 52-75,范围0-107岁),39.7%为女性。
诊断标准与关键阈值
- 鼻咽样本聚合酶链反应检测SARS-CoV-2阳性且需住院。
研究设计与关键结果
- 研究类型为病例系列,纳入12家医院连续住院的5700例COVID-19患者。
- 最常见合并症:高血压3026例(56.6%)、肥胖1737例(41.7%)、糖尿病1808例(33.8%)。
- 分诊时30.7%发热,17.3%呼吸频率大于24次/分,27.8%接受补氧,呼吸道病毒共感染率2.1%。
- 对终点时已出院或死亡的2634例评估结局:373例(14.2%)入住ICU,320例(12.2%)接受有创机械通气,81例(3.2%)接受肾脏替代治疗,553例(21%)死亡。
- 截至2020年4月4日,需机械通气的1151例(20.2%)中38例(3.3%)存活出院、282例(24.5%)死亡、831例(72.2%)仍在院。
- 出院后中位随访4.4天(IQR 2.2-9.3),45例(2.2%)再入院,再入院中位时间3天(IQR 1.0-4.5)。
- 最终随访日仍有3066例在院(中位年龄65岁,IQR 54-75),删失时中位随访4.5天(IQR 2.4-8.1)。
证据类型、等级与局限
- 证据类型:病例系列。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该病例系列提供了纽约地区COVID-19住院患者早期特征与结局,插管患者出院存活率低(3.3%),提示对需有创机械通气者预后应审慎评估。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: There is limited information describing the presenting characteristics and outcomes of US patients requiring hospitalization for coronavirus disease 2019 (COVID-19).
OBJECTIVE: To describe the clinical characteristics and outcomes of patients with COVID-19 hospitalized in a US health care system.
DESIGN, SETTING, AND PARTICIPANTS: Case series of patients with COVID-19 admitted to 12 hospitals in New York City, Long Island, and Westchester County, New York, within the Northwell Health system. The study included all sequentially hospitalized patients between March 1, 2020, and April 4, 2020, inclusive of these dates.
EXPOSURES: Confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection by positive result on polymerase chain reaction testing of a nasopharyngeal sample among patients requiring admission.
MAIN OUTCOMES AND MEASURES: Clinical outcomes during hospitalization, such as invasive mechanical ventilation, kidney replacement therapy, and death. Demographics, baseline comorbidities, presenting vital signs, and test results were also collected.
RESULTS: A total of 5700 patients were included (median age, 63 years [interquartile range {IQR}, 52-75; range, 0-107 years]; 39.7% female). The most common comorbidities were hypertension (3026; 56.6%), obesity (1737; 41.7%), and diabetes (1808; 33.8%). At triage, 30.7% of patients were febrile, 17.3% had a respiratory rate greater than 24 breaths/min, and 27.8% received supplemental oxygen. The rate of respiratory virus co-infection was 2.1%. Outcomes were assessed for 2634 patients who were discharged or had died at the study end point. During hospitalization, 373 patients (14.2%) (median age, 68 years [IQR, 56-78]; 33.5% female) were treated in the intensive care unit care, 320 (12.2%) received invasive mechanical ventilation, 81 (3.2%) were treated with kidney replacement therapy, and 553 (21%) died. As of April 4, 2020, for patients requiring mechanical ventilation (n = 1151, 20.2%), 38 (3.3%) were discharged alive, 282 (24.5%) died, and 831 (72.2%) remained in hospital. The median postdischarge follow-up time was 4.4 days (IQR, 2.2-9.3). A total of 45 patients (2.2%) were readmitted during the study period. The median time to readmission was 3 days (IQR, 1.0-4.5) for readmitted patients. Among the 3066 patients who remained hospitalized at the final study follow-up date (median age, 65 years [IQR, 54-75]), the median follow-up at time of censoring was 4.5 days (IQR, 2.4-8.1).
CONCLUSIONS AND RELEVANCE: This case series provides characteristics and early outcomes of sequentially hospitalized patients with confirmed COVID-19 in the New York City area.
参考来源
- Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020. PMID: 32320003. doi:10.1001/jama.2020.6775
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。